Keeping Current CME

Chronic Rhinosinusitis With Nasal Polyps Reimagined: Bridging Surgery and Biologics to Improve Patient Outcomes

·22 min·2 clips
Dr. Hahn reveals how irritants trigger a cascade of cytokines like IL-5 and IL-13 that directly cause nasal polyps to form.
The program opens with chronic rhinosinusitis with nasal polyps as a disease that can come back despite appropriate medical treatment and surgery. It places biologics within the care of patients with recalcitrant disease. The presenters identify three approved biologics and note that additional options may be nearing clinical use. They review safety information from phase three studies alongside post-market data. The discussion describes biologics targeting type 2 respiratory disease as having a favorable safety profile. Local injection-site effects get specific attention as common adverse effects. Clinical selection becomes the next practical decision point. The presenters describe patients whose polyps recur despite topical steroids and systemic steroids. Failed surgery also becomes part of the criteria for considering biologic treatment. High symptom burden and high endoscopy nasal polyp scores further define the population under discussion. The program references high-volume steroid nasal rinses and exhalant steroid delivery systems as contemporary treatment approaches. Consensus work from Europe and the United States is introduced through the Euphoria group. Its proposed criteria include evidence of type 2 nasal inflammation. The framework also considers systemic corticosteroid use or contraindication to steroids. A SNOT-22 score greater than 40 is included as a marker of symptom burden. Smell loss and comorbid asthma are also part of the clinical picture. The presenters connect recurrence risk to the mechanisms driving the polyps. Blood eosinophils, the level of atopy, and asthma may help with that assessment. The closing summary emphasizes that different nasal polyp types require attention to underlying biology. The activity concludes with a reminder to complete the post-test and evaluation.

As heard by us

A practical review of why recurrent nasal polyps often call for both biological insight and broader treatment planning.

Chronic rhinosinusitis with nasal polyps is treated here as a persistent clinical problem, not a one-time surgical fix. The discussion ties topical and systemic steroids, surgery, steroid delivery systems, and biologics to patients whose disease keeps coming back, with a steady…

Read the full review in PlayNext →

Why you'd press play

You want a clearer map for what can happen when chronic sinusitis with nasal polyps keeps coming back after appropriate treatment.

Read the full recommendation in PlayNext →
Listen to the show on